Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients
Palabras clave
Abstracto
fechas
Verificado por última vez: | 01/31/2012 |
Primero enviado: | 12/20/2007 |
Inscripción estimada enviada: | 12/20/2007 |
Publicado por primera vez: | 01/02/2008 |
Última actualización enviada: | 12/11/2019 |
Última actualización publicada: | 12/12/2019 |
Fecha de inicio real del estudio: | 11/30/2006 |
Fecha estimada de finalización primaria: | 12/31/2011 |
Fecha estimada de finalización del estudio: | 12/31/2011 |
Condición o enfermedad
Intervención / tratamiento
Procedure: 1 CNS
Procedure: 1 CNS
Procedure: 2. Head and Neck
Procedure: 3. Lung
Procedure: 4. Prostate
Procedure: 5. Esophagus
Fase
Grupos de brazos
Brazo | Intervención / tratamiento |
---|---|
Experimental: 1 CNS imaging with CuATSM | Procedure: 1 CNS imaging with CuATSM |
Experimental: 2. Head and Neck Imaging with CuATSM | Procedure: 2. Head and Neck Imaging with CuATSM |
Experimental: 3. Lung imaging with CuATSM | Procedure: 3. Lung imaging with CuATSM |
Experimental: 4. Prostate PET imaging with CuATSM | Procedure: 4. Prostate Imaging with CuATSM |
Experimental: 5. Esophagus PET imaging with CuATSM | Procedure: 5. Esophagus Imaging with CuATSM |
Criterio de elegibilidad
Edades elegibles para estudiar | 18 Years A 18 Years |
Sexos elegibles para estudiar | All |
Acepta voluntarios saludables | si |
Criterios | Inclusion Criteria: - Able to tolerated a PET/CT scan - Age 18 or older - Patient being considered for XRT for treatment of their cancer - Able to provide written informed consent Exclusion Criteria: - severe claustrophobia or inability to tolerate the PET scan - pregnant or breastfeeding women - Patients that need supplemental oxygen - Patients enrolled in experimental treatments |
Salir
Medidas de resultado primarias
1. To validate the CuATSM-PET imaging by correlation to the serum level of osteopontin, a marker of hypoxia [end of study]
Medidas de resultado secundarias
1. To test reliability of the CuATSM uptake by quantifying the reproducibility of the pre-treatment CuATSM_PET scans [end of study]
2. To assess the technical and logistic feasibility of CuATSM-PET scans in a population of cancer patients [end of study]